Prenatal maternal stress and atopic diseases in the child: a systematic review of observational human studies NW Andersson, MV Hansen, AD Larsen, KS Hougaard, HA Kolstad, ... Allergy 71 (1), 15-26, 2016 | 177 | 2016 |
Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study NW Andersson, LN Gustafsson, N Okkels, F Taha, SW Cole, ... Psychological medicine 45 (16), 3559-3569, 2015 | 103 | 2015 |
Depression and the risk of severe infections: prospective analyses on a nationwide representative sample NW Andersson, RD Goodwin, N Okkels, LN Gustafsson, F Taha, SW Cole, ... International journal of epidemiology 45 (1), 131-139, 2016 | 99 | 2016 |
Loneliness, health and mortality J Henriksen, ER Larsen, C Mattisson, NW Andersson Epidemiology and psychiatric sciences 28 (2), 234-239, 2019 | 70 | 2019 |
Influence of prenatal maternal stress on umbilical cord blood cytokine levels NW Andersson, Q Li, CW Mills, J Ly, Y Nomura, J Chen Archives of women's mental health 19, 761-767, 2016 | 63 | 2016 |
Comparative effectiveness of the bivalent BA. 4-5 and BA. 1 mRNA-booster vaccines in the Nordic countries NW Andersson, EM Thiesson, U Baum, N Pihlstrom, J Starrfelt, K Faksova, ... bmj 382, 2023 | 54 | 2023 |
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation NW Andersson, H Svanström, M Lund, B Pasternak, M Melbye International Journal of Cardiology 268, 113-119, 2018 | 33 | 2018 |
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study NW Andersson, L Skov, JT Andersen Rheumatology 60 (5), 2317-2326, 2021 | 26 | 2021 |
Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study NW Andersson, RH Olsen, JT Andersen bmj 372, 2021 | 23 | 2021 |
Evaluation of association between oral and topical terbinafine use in pregnancy and risk of major malformations and spontaneous abortion NW Andersson, SF Thomsen, JT Andersen JAMA dermatology 156 (4), 375-383, 2020 | 22 | 2020 |
Association between fexofenadine use during pregnancy and fetal outcomes NW Andersson, C Torp-Pedersen, JT Andersen JAMA pediatrics 174 (8), e201316-e201316, 2020 | 21 | 2020 |
Desloratadine use during pregnancy and risk of adverse fetal outcomes: a nationwide cohort study NW Andersson, HE Poulsen, JT Andersen The Journal of Allergy and Clinical Immunology: In Practice 8 (5), 1598-1605, 2020 | 21 | 2020 |
High‐Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta‐Adrenoceptor Blockade: A Randomized Clinical Trial KM Petersen, S Bøgevig, T Riis, NW Andersson, KP Dalhoff, JJ Holst, ... Journal of the American Heart Association 9 (21), e016828, 2020 | 17 | 2020 |
Risk of childhood asthma following prenatal exposure to negative life events and job stressors X Liu, KP Madsen, CS Sejbaek, HA Kolstad, JPE Bonde, J Olsen, ... Scandinavian journal of work, environment & health 45 (2), 174-182, 2019 | 13 | 2019 |
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses NW Andersson, EM Thiesson, U Baum, N Pihlström, J Starrfelt, K Faksová, ... bmj 382, 2023 | 12* | 2023 |
Adverse childhood experiences and asthma: trajectories in a national cohort K Pape, W Cowell, CS Sejbaek, NW Andersson, C Svanes, HA Kolstad, ... Thorax 76 (6), 547-553, 2021 | 12 | 2021 |
Risk of stroke subsequent to infective endocarditis: a nationwide study L Østergaard, NW Andersson, SL Kristensen, A Dahl, H Bundgaard, ... American Heart Journal 212, 144-151, 2019 | 12 | 2019 |
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study NW Andersson, EM Thiesson, MV Laursen, SH Mogensen, J Kjær, ... Bmj 378, 2022 | 11 | 2022 |
Safety of BA. 4-5 or BA. 1 bivalent mRNA booster vaccines: nationwide cohort study NW Andersson, EM Thiesson, JV Hansen, A Hviid bmj 382, 2023 | 9* | 2023 |
Association between fetal safety outcomes and exposure to local podophyllotoxin during pregnancy NW Andersson, JT Andersen JAMA dermatology 156 (3), 303-311, 2020 | 9 | 2020 |